PharmaVentures Acted As Advisor For Sale of PhotoBioChem, N.V. Patent Assets to SpectraCure, AB

PharmaVentures announced today that it had acted as an advisor and broker to the PhotoBioChem, N.V. Holland for the sale of its patent assets to SpectraCure AB, Sweden.

Oxford, UK (PRWEB) April 7, 2008 -- PharmaVentures announced today that it had acted as an advisor and broker to the PhotoBioChem, N.V. Holland for the sale of its patent assets to SpectraCure AB, Sweden.

Dr Fintan Walton, CEO, PharmaVentures said, We were delighted to bring another successful outcome for one of our clients. We were proud to act as advisors and facilitators to PhotoBioChem in the divestment of its patent portfolio".

About PharmaVentures PharmaVentures www.pharmaventures.com assists pharmaceutical and biotechnology companies across the world in all aspects of deal making. The Company's core business is the provision of tailored transaction advisory services to the Life Science industry. PharmaVentures is based in Oxford, UK, and employs over 35 people. With offices in the USA and Australia, the Company works for a variety of clients from start-ups to global corporations.

Contact Information
Fiona Bishop on +44 (0)1865 784 187 fiona.bishop@pharmaventures.com PharmaVentures Ltd, Magdalen Centre, Oxford Science Park, Oxford OX4 4GA, UK

###

• PharmaVentures and Growthink Research Join Forces to Deliver Bioscience Industry Information Solutions 2008-05-21
• Major New Report Highlights Growing Importance of IP Strategies and Competition Law in the Pharmaceuticals Industry 2008-04-17
• PharmaVentures Acted as Advisor for Sale of Dowpharma Small Molecules Business to Dr Reddy’s Laboratories 2008-04-04
• Anne Vindenes Allen Joins PharmaVentures Ltd to Head Publishing Operations 2008-03-20